Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

OTC Drug Firms' Online Subscription Sales Would Jeopardize Retail Partnerships

Executive Summary

OTC drug firms would cannibalize their sales at retailers if they offer online subscription sales, the rapidly growing e-commerce model that offers advantages that appeal to consumers, says former P&G marketing executive Brent Walker.

You may also be interested in...



Retailers Get Personal To Compete With E-commerce In Consumer Health

Traditional retailers including Kmart, Walgreens and CVS are responding to e-commerce threat by adopting technology and programs customized to shoppers’ preferences and lifestyles, says IRI Exec VP Robert Sanders. Consumer health firms are angling to find a place for their brands within the programs.

Retailers Get Personal To Compete With E-commerce In Consumer Health

Traditional retailers including Kmart, Walgreens and CVS are responding to e-commerce threat by adopting technology and programs customized to shoppers’ preferences and lifestyles, says IRI Exec VP Robert Sanders. Consumer health firms are angling to find a place for their brands within the programs.

Vitamin Shoppe Turnaround Tools Include Auto-Delivery, Price-Matching

The firm has looked to boost sales through a retail re-invention strategy for improving customers' shopping experience with better store layouts, product assortment and website improvements. Now it’s using tools “directly focused on customer acquisition, price/value and customer retention,” CEO Colin Watts says.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

LL1125120

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel